Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.

Arthritis research & therapy

Volumn 7, Issue 6, 2005, Pages

  Omoto, Atsushi ^a   Kawahito, Yutaka ^a   Prudovsky, Igor ^a   Tubouchi, Yasunori ^a   Kimura, Mizuho ^a   Ishino, Hidetaka ^a   Wada, Makoto ^a   Yoshida, Makie ^a   Kohno, Masataka ^a   Yoshimura, Rikio ^a   Yoshikawa, Toshikazu ^a   Sano, Hajime ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHELATING AGENT; COPPER; MOLYBDENUM; TETRATHIOMOLYBDIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; ARTHRITIS; ARTICLE; BLOOD; CACHEXIA; CHELATION THERAPY; DISEASE MODEL; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; HINDLIMB; JOINT; LEWIS RAT; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT; SYNOVIUM;

ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CACHEXIA; CHELATING AGENTS; CHELATION THERAPY; COPPER; DISEASE MODELS, ANIMAL; FEMALE; HINDLIMB; IMMUNOENZYME TECHNIQUES; JOINTS; MOLYBDENUM; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33644665507     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: None     Document Type: Article

References (0)